Shi-Kai Tian

This inventor holds 4 USPTO granted patents. Top assignees: Vertex Pharmaceuticals, Inc., Brandeis University. Active years: 2006-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shi-Kai Tian. Retrieved from https://idiyas.com/inventor/shi-kai-tian

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4

% Patents Active = 25.0

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 24(Granted Patents)

Company Filing History:

3 out of 1,167

Vertex Pharmaceuticals, Inc.

Years Active: 2006-2011

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7902239 - Diaminotriazoles useful as inhibitors of protein kinases (2011-03-08),

2. 7485664 - Inhibitors of TACE (2009-02-03),

3. 7279469 - Diaminotriazoles useful as inhibitors of protein kinases (2007-10-09),

4. 7078547 - Catalytic asymmetric cyanosilylation of ketones, aldehydes, thioketones, thioaldehydes, imines and hydrazones (2006-07-18),

Title: Shi-Kai Tian: Innovator in Protein Kinase Inhibition

Introduction

Shi-Kai Tian is a prominent inventor based in Waltham, MA (US). She has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for protein kinases. With a total of 4 patents to her name, her work has the potential to impact various medical treatments.

Latest Patents

Among her latest patents is a groundbreaking invention titled "Diaminotriazoles useful as inhibitors of protein kinases." This invention relates to inhibitors of protein kinases and provides pharmaceutical compositions that comprise these compounds. The methods outlined in this patent aim to treat various disorders effectively. Another notable patent is for "Inhibitors of TACE," which focuses on compounds that inhibit TACE, along with their compositions and methods for treating diseases.

Career Highlights

Shi-Kai Tian has worked with esteemed organizations such as Vertex Pharmaceuticals, Inc. and Brandeis University. Her experience in these institutions has allowed her to collaborate with leading experts in her field and contribute to innovative research.

Collaborations

Some of her notable coworkers include Albert Charles Pierce and Robert J. Davies. Their collaborative efforts have further advanced the research and development of her patented inventions.

Conclusion

Shi-Kai Tian's contributions to the field of protein kinase inhibition demonstrate her innovative spirit and dedication to advancing medical science. Her patents reflect her commitment to developing effective treatments for various disorders.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]